Neil A Klompas insider trades

Open-market stock purchases and sales by Neil A Klompas, Director at InMed Pharmaceuticals Inc, from SEC Form 4 filings since May 6, 2019.

Recent trades

DateStockTradeValue
Dec 19, 2025INM InMed Pharmaceuticals IncBought (not open market)—

Companies traded

  • INM InMed Pharmaceuticals Inc: other filings, last Dec 19, 2025
  • ZYME Zymeworks Inc: 7 sales, last Mar 10, 2023

Get free alerts when Neil A Klompas files a new trade →